恶性胶质瘤端粒维持机制及相关治疗脆弱性
综述总结儿童与成人恶性胶质瘤中端粒酶激活或ALT两种端粒维持机制的遗传改变与分子机制,并梳理靶向这些机制的新兴治疗证据及转化gap。
要点
- 约85%的癌症激活端粒酶维持端粒长度,端粒酶阴性癌症通过ALT机制维持端粒。
- 儿童与成人恶性胶质瘤几乎普遍激活端粒酶或ALT,频率因遗传定义的胶质瘤亚型而异。
- 综述梳理靶向端粒维持机制的新兴证据及推动领域转化的关键缺口。
核心结论
- 儿童与成人恶性胶质瘤几乎普遍激活端粒酶或ALT,频率因遗传定义的胶质瘤亚型而异。
- 综述总结了靶向端粒维持机制的新兴证据,并指出将端粒维持认识转化为更好治疗策略的关键缺口。
研究设计与样本
- 综述,总结端粒维持机制领域现状及其与胶质瘤生物学和治疗的相关性。
主要发现
- 约85%的癌症激活端粒酶以在多轮细胞分裂中维持端粒长度。
- 端粒酶阴性癌症激活ALT,ALT利用同源重组维持端粒长度并表现断裂诱导DNA复制特征。
- 儿童与成人恶性胶质瘤几乎普遍激活端粒酶或ALT,频率因遗传定义的胶质瘤亚型而异。
关键数值与推荐
- 约85%的癌症激活端粒酶维持端粒长度。
- 端粒酶阴性癌症激活ALT,ALT利用同源重组维持端粒长度并表现断裂诱导DNA复制特征。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A majority of cancers (~85%) activate the enzyme telomerase to maintain telomere length over multiple rounds of cellular division. Telomerase-negative cancers activate a distinct, telomerase-independent mechanism of telomere maintenance termed alternative lengthening of telomeres (ALT). ALT uses homologous recombination to maintain telomere length and exhibits features of break-induced DNA replication. In malignant gliomas, the activation of either telomerase or ALT is nearly ubiquitous in pediatric and adult tumors, and the frequency with which these distinct telomere maintenance mechanisms (TMMs) is activated varies according to genetically defined glioma subtypes. In this review, we summarize the current state of the field of TMMs and their relevance to glioma biology and therapy. We review the genetic alterations and molecular mechanisms leading to telomerase activation or ALT induction in pediatric and adult gliomas. With this background, we review emerging evidence on strategies for targeting TMMs for glioma therapy. Finally, we comment on critical gaps and issues for moving the field forward to translate our improved understanding of glioma telomere maintenance into better therapeutic strategies for patients.
引用
- Waitkus MS, Erman EN, Reitman ZJ, et al. Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas. Neuro Oncol. 2024. PMID: 38285162. doi:10.1093/neuonc/noae016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。